Table 3 Shows characteristics of allografts with post-transplant MPGN recurrence
Graft | MPGN type (Native/Rec) | Age at Txp | Sex/Race | Donor | Months to recurrence | sCr | Proteinuria(g) | Rx | Graft status/sCr | |
|---|---|---|---|---|---|---|---|---|---|---|
By EM | By IF | |||||||||
1 | 1/1 | IC/IC | 20 | F/AA | LR | 2 | 1.4 | 4 | None | Functional/1.6 |
2 | 1 a/1 | IC/IC | 39 | F/C | LR | 3 | 1.2 | 9 | CS + ACEi | Functional/ 2.5 |
3 | 1 a/1 | C3/IC | 59 | F/C | LR | 1 | 0.9 | 2.7 | None | Functional/0.9 |
4 | 1/1 | IC/IC | 26 | M/C | LR | 24 | 2 | 2.3 | Ritux + CS | Lost in 22 mos |
5 | 2 + 3/2 + 3 | IC/IC | 53 | M/C | D | 24 | 3 | NA | CS | Lost in 96 mos |
6 | 3 a/1 | IC/IC | 18 | M/I | LU | 36 | 2.5 | 4 | TPE + CS | Lost in 4 mos |
7 | 3 a/? | IC/IC | 15 | M/I | LR | 18 | NA | NA | None | Lost in 1 mos |
8 | 1/1 | IC/IC | 28 | M/A | LR | 6 | 1.8 | 0.1 | Ritux | Functional/1.2 |
9 | 1/1 | IC/IC | 54 | M/AA | D | 4 | 1.0 | 2 | ACEi | Functional/1.0 |
10 | 1/1 | IC/IC | 53 | M/C | D | 4 | 1.7 | 0.5 | TPE+ ACEi | Functional/1.2 |
11 | 3a/1 | IC/IC | 30 | F/C | LR | 108 | 2.0 | 0.45 | Ritux | Functional/2.5 |
12 | 2/2 | IC/IC | 54 | M/C | LU | 24 | 3.4 | NA | Ritux | Lost in 2 mos |
13 | 1/1 | IC/IC | 51 | F/C | LU | 1 | 1.9 | 0.8 | TPE + Ritux | Functional/1.7b |
14 | 1a/1 | IC/IC | 32 | M/H | LR | 24 | 1.7 | 4 | TPE + Ritux | Lost in 41 mos |
15 | 1/1 | IC/IC | 25 | F/C | LR | 14 | 1.3 | 9.5 | Ritux | Lost in 4 mos |
16 | 1/1 | IC/IC | 53 | F/AA | LR | 12 | NA | NA | CS | Lost in 8 mos |
17 | 1/2 | IC/C3 | 58 | F/AA | D | 6 | 3.1 | NA | None | Lost in 5 mos |
18 | 1/1 | C3/C3 | 24 | M/C | LU | 3 | 1.3 | 0.2 | Eculizumab | Functional/1.3 |